Assembly Biosciences (ASMB) Misses Q3 EPS by 72c

Assembly Biosciences (NASDAQ: ASMB) reported Q3 EPS of ($0.72). Revenue for the quarter came in at $10.79 million.

For earnings history and earnings-related data on Assembly Biosciences (ASMB) click here.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• Enovis launches CT-RevitL laser therapy system for veterinary use
• Mingteng International launches ERP and MES systems at China facility